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Abstract: The immune system is exquisitely sensitive to environmental changes. Diet 
constitutes one of the major environmental factors that exerts a profound effect on immune 
system development and function. Epigenetics is the study of mitotically heritable, yet 
potentially reversible, molecular modifications to DNA and chromatin without alteration to 
the underlying DNA sequence. Nutriepigenomics is an emerging discipline examining the 
role of dietary influences on gene expression. There is increasing evidence that the epigenetic 
mechanisms that regulate gene expression during immune differentiation are directly 
affected by dietary factors or indirectly through modifications in gut microbiota induced by 
different dietary habits. Short-chain fatty acids, in particular butyrate, produced by selected 
bacteria stains within gut microbiota, are crucial players in this network. 
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1. Introduction 
The immune system is exquisitely sensitive to environmental changes. One of the clearest reflections 
of this is the recent and dramatic rise in immune-mediated diseases, mainly allergies, with progressive 
modern urbanization. 
Diet constitutes one of the major environmental factor that exerts a crucial effect on immune system 
development and function, and thus, it greatly influences many aspects of health and disease risk [1,2]. 
The rise in allergic diseases is fast becoming a major global health issue. While this was first evident 
in more developed countries of Australasia, Western Europe and North America, where more than 40% 
of the population may be affected at some stage [3,4], it is now also emerging in virtually all regions of 
the world undergoing industrial development and Westernization [5]. International trends provide some 
indication that environmental changes can affect immune function regardless of the genetic background. 
There is emerging evidence that the epigenetic mechanisms that regulate gene expression during immune 
differentiation are susceptible to these environmental influences [1]. Epigenetics is the study of 
mitotically heritable, yet potentially reversible, molecular modifications to DNA and chromatin without 
alteration to the underlying DNA sequence [6,7]. Increasingly, it is recognized that epigenetic marks 
provide a mechanistic link between environment, nutrition and disease. Though the DNA sequence is 
fairly permanent, epigenetic modifications are dynamic throughout the life course and can be heavily 
influenced by external factors [7]. The epigenetic program is encoded by specific histone modifications 
(methylation and acetylation) and DNA methylation patterns, which determine the degree of DNA 
compaction and, thus, the accessibility of genes for transcription. In addition to histone modifications 
and DNA methylation, there are also other gene regulatory networks, including microRNAs, small 
interfering RNAs and long non-coding RNAs, all of which serve to control gene expression [8]. Given 
that these modifications are reversible and sensitive to environmental factors, they provide a mechanistic 
link between environmental exposures, developmental programming and the risk for disease [9]. Early 
life nutrition may influence immune system development through direct epigenetic mechanisms. Some 
nutritional factors, like folate and vitamins B1, B2 and B12, can change DNA methylation [10]. Retinoic 
acid, garlic and dietary protein restriction may cause histone modification, and bioactive food 
compounds, like curcumin, genistein and retinoic acid, can decrease carcinogenic expression by  
miRNA [10]. Alternatively, dietary factors could influence epigenetic regulation of gene expression 
through an indirect mechanism mediated by a modulation of gut microbiota. The major metabolites 
produced by gut microbiota are short-chain fatty acids (SCFAs), such as butyrate, that have multiple 
beneficial effects at the intestinal and extra-intestinal level [11]. As more dietary fibers are ingested, 
SCFAs production increases [12]. The circulating SCFAs have a regulatory effect on macrophage and 
dendritic cell (DC) biology, supporting a strong connection between dietary fibers intake and immune 
response controlled by these cells [13]. Interestingly, the placenta has recently been shown to contain 
commensal microbes [14]. This suggests a potential role for maternal diet through an effect on placental 
commensal microbes on immune pathways during fetal development. Similarly, metabolites from gut 
microbiota, such as SCFAs, are present in breast milk, and this might be an important point of interaction 
between metabolites and the immune system [15–18]. 
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2. Nutritional Epigenetic Effects on Early Development 
Maternal nutrition plays an essential role in offspring health and development. Critical stages include: 
preconception, affecting oocyte development and uterine environment preparation, gestation, affecting 
uterine environment and placental nutrient transfer, and postnatal, through lactation [19–21]. It remains 
debatable which stage is most important, but arguably the most complex cellular events occur during 
gestation. During this time, embryo development requires a well-orchestrated and tightly-regulated 
cascade of genetic, molecular and biochemical events. New data reinforce the importance of in utero 
exposures to nutrients in fetal immune development and in programming the susceptibility to allergic 
diseases [22]. Prenatal environmental exposures may have important and permanent effects on 
epigenetic mechanisms. Nutriepigenomics is an emerging discipline examining the role of dietary 
influences on gene expression. Ultimately, DNA methylation events and dietary practices, particularly 
micronutrient intake, may influence disease phenotypes [23] (Table 1). Methylation occurs after 
replication and almost exclusively affects position five of the pyrimidine ring of cytosines in the context 
of the dinucleotide sequence, CpG [24]. Approximately 75% of mammalian CpG dinucleotides are 
methylated. Clusters enriched in CpGs (CpG islands) are found in locus control regions, promoter 
regions and the first exons of many genes. Throughout the genome, CpG islands are generally much less 
methylated, potentially allowing transcription [25]. The methyl groups needed for all biological 
methylation reactions are derived from methyl donors and from cofactors carrying one-carbon units. A 
key pathway of these reactions is the metabolic cycling of methionine [26]. Novel experiments 
investigating maternal methyl donor supplementation in utero clearly demonstrated the impact of early 
nutrition epigenome shaping. Hypermethylation of a gene crucial in lymphocyte regulation, Runx3, 
arising in offspring exposed to methyl donors in utero has been considered to be involved in increased 
allergic airway disease development and severity [27]. Furthermore, C57BL/6 mice exposed to methyl 
donor supplementation in utero exhibited enhanced colitis susceptibility, which was also associated with 
aberrant DNA methylation among genes associated with immunologic processes [28]. Dietary folate is 
the most extensively studied micronutrient in animal and epidemiological DNA methylation research. 
Folate is reduced to dihydrofolate (DHF) and subsequently to tetrahydrofolate (THF), serving as a single 
carbon donor in the form of 5-methyl THF. Consequently, 5-methyl THF feeds into the one-carbon 
metabolism cycle by donating its methyl group to homocysteine, converting it to methionine. Cofactor 
B vitamins provide the enzymatic support necessary for these transformations, making it possible for 
dietary folate to feed into the one-carbon metabolism cycle to replenish cellular S-adenosyl-methionine 
(SAM). For this reason, folate supplementation has generally been associated with increased DNA 
methylation and vice versa for folate restriction [25]. A study on rats found that normal dietary folate 
levels with supplemental selenium yielded greater methylation of DNA in colon and liver than when 
diets contained only one or neither of the two nutrients [29]. Another study investigated the effect of 
folate deficiency during pregnancy and lactation and of high-fat feeding from weaning on DNA 
methylation and the expression of selected genes in adult offspring brain in a mouse model. The results 
suggest that low folate supply during early life may cause an epigenetic effect in offspring, leading to an 
increased sensibility to further dietary insults [30]. 
Human studies have also investigated the role of maternal folate status and offspring methylation. A 
cross-sectional study of pregnant women at the time of delivery looked at the imprinted gene Igf2 [31]. 
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Cord blood and maternal blood were collected at time of delivery, and serum folate concentrations were 
determined for both specimens [32]. Methylation-specific PCR determined that maternal and cord blood 
folate concentrations were not associated with methylation outcomes in the P2 and P3 promoters of Igf2. 
Additionally, hypomethylation within the Igf2 promoter of umbilical cord blood leukocytes was 
inversely associated with maternal report of folate supplementation during pregnancy [33]. Maternal 
plasma folate and homocysteine levels and/or polymorphisms in folate metabolizing genes have been 
implicated in inorganic arsenic (iAs) metabolism, a common, naturally occurring drinking water 
contaminant, and in susceptibility to iAs toxicity [34,35]. Tsang et al. showed that in utero exposure of 
mice to iAs, combined with high gestational folate intake, results in low fetal weight at gestation Day 
18, dramatic changes in global DNA methylation in fetal liver and in aberrant CpG island methylation 
of genes associated with fetal development [36]. In another study, Schaible et al. provided evidence that 
maternal methyl-donors (MDs) supplementation increases offspring colitis susceptibility, which is 
associated with persistent epigenetic and prolonged microbiomic changes. These findings underscore 
that epigenomic reprogramming relevant to mammalian colitis can occur during early development in 
response to maternal dietary modifications and suggest that the prenatal reprogramming of mucosal 
immunology upon maternal MDs supplementation creates a persistent effect on the enteral microbiome 
by inducing a longstanding modification of its physiologic development [28]. Another study examined 
the effect of methyl donor-restricted (MR) and methyl donor-supplemented (MS) diets on the expression 
of methylation-sensitive T-cell genes and lupus disease, using a mouse model. The authors found that 
MS diet reduced anti-dsDNA antibody to near background levels in transgenic mice with defective  
Erk-triggered lupus-like disease, suggesting that micronutrients that enhance transmethylation reactions 
may ameliorate lupus disease via epigenetic mechanisms. Similarly, the reduced methionine content of 
the MR diet, together with reduced Erk pathway activity, could have exacerbated lupus disease via 
epigenetic mechanisms by causing DNA hypomethylation and enhanced immune gene expression [37]. 
Choline and betaine are indirect methyl group donors for one-carbon metabolism. Choline deficiency 
during gestational Days 12–17 decreased methylation within a CpG site located in the Calb1 promoter 
of the fetal hippocampus [38]. Wang et al. identified a new direct link between the gut microbiota-
dependent metabolism of dietary phosphatidylcholine and cardiovascular disease pathogenesis, which 
represents a leading cause of death and morbidity worldwide. These results suggest that an appropriately-
designed probiotic intervention may serve as a preventive and therapeutic strategy for these  
conditions [39]. Hypermethylation at the DMR 2 of Igf2 in rat liver, following exposure to a  
choline-deficient diet from embryonic Days 11–17, was correlated with hypomethylation of CpG sites 
within Dnmt1 (DNA methyltransferase 1), the gene encoding DNA methyltransferase, and these results 
suggest that early choline-deficiency is able to deprive DNA methylation machinery of proper substrates 
of one-carbon metabolism, leading to increased expression of methyltransferases [40]. Vitamins B6 and 
B12 are cofactors involved in the regulation of the catalytic activity of enzymes from the folate cycle, 
thus determining SAM bioavailability. Supplementing diets with these vitamins will contribute to the 
maintenance or establishment of DNA methyl marks [2]. High ethanol consumption inhibits the 
availability of vitamins B6 and B12, thus interfering with the production of SAM and appropriate DNA 
methylation, through the folate/methionine cycles [41]. 
Ba et al. assessed vitamin B12 and folate status in pregnant women at the time of birth. Cord blood 
Igf2 methylation at the P3 promoter was inversely correlated with the maternal serum level of vitamin 
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B12. Additionally, maternal blood methylation in the P2 promoter was inversely correlated with 
maternal serum vitamin B12 level [32]. A wide range of nutrients, including fat feeding, protein, alcohol, 
vitamin E, hormones and a number of polyphenols, may alter expression of specific miRNAs [42–45]. 
Recent studies show that maternal high fat feeding during gestation and lactation changed the expression 
of 23 miRNAs in liver in the offspring [46]. Keller et al. showed that a large set of miRNAs in the 
skeletal muscle of obese Zucker rats is responsive to carnitine supplementation, suggesting a novel 
mechanism through which carnitine exerts its multiple effects on gene expression [47]. Vitamin E 
deficiency in rats caused a downregulation of miR-122a and miR-125b, which contribute to regulating 
lipid metabolism and inflammation, respectively [48]. Wang et al. observed that maternal exposure to 
ethanol also changed the expression of several miRNAs in the fetal brain from the offspring [49]. There 
are also some studies linking macro-nutrition (e.g. carbohydrates) to transgenerational epigenetic 
changes and immune disease. Miao et al. [50] reported that after chronic exposure of the human 
monocytic cell line, THP-1, to high glucose, histone 3 acetylation at lysine 9 and lysine 14 was increased 
at the TNF-α and COX-2 promoters. Another study showed that transient exposure to hyperglycemia 
induced long-lasting activating epigenetic changes in the promoter of the nuclear factor kB subunit p65 
in aortic endothelial cells, both in vitro and in non-diabetic mice. They found that an increase of 
monomethylation of histone 3 lysine 4 by the histone methyltransferase Set7, in the proximal promoter 
region of p65, caused an upregulation of p65 gene expression, leading to a sustained increase in the 
expression of the NF-κB-responsive proatherogenic genes, MCP-1 and VCAM-1 [51]. These epigenetic 
changes persist for at six days and may be responsible for the persistent atherogenic effects during 
subsequent normoglycemia [51]. Recent findings showed that the hyperglycemic intrauterine 
environment of gestational diabetes mellitus (GDM) results in a high risk of diabetes in offspring by 
altering epigenetic modification. In addition to intergenerational transmission (F1 offspring), intrauterine 
hyperglycemia may also have effects on the second generation (F2 offspring) [52]. Using a GDM mouse 
model, the authors demonstrated that the expression of imprinted genes Igf2 and H19, in both F1 and F2 
offspring, was downregulated in pancreatic islets, caused by abnormal methylation status of the 
differentially methylated region, which may be one of the mechanisms for impaired islet ultrastructure 
and function. Altered Igf2 and H19 gene expression was also found in sperm of adult F1-GDM with or 
without impaired glucose tolerance, indicating that epigenetic changes in germ cells contributed to 
transgenerational transmission [52]. 
Table 1. Main nutritional factors influencing the immune system through an  
epigenetic mechanism. 
Nutritional Factors Epigenetic Mechanism 
Folic acid DNA methylation [25,29–36] 
Choline and betaine DNA methylation [38–40] 
Vitamins DNA methylation [2,32] microRNAs [48] 
Dietary fibers  
(butyrate production by gut microbiota) [12] 
DNA methylation [21] 
Histone modifications [10,53] 
Fat feeding, protein, hormones microRNAs [42–45] 
Ethanol DNA methylation [41] microRNAs [42–45,49] 
Carbohydrates DNA methylation [50–52] 
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3. Gut Microbiota as a Nutriepigenomic Player 
Gut microbiota plays a critical role in the establishment and maintenance of body health (Figure 1). 
Commensal bacteria are involved in the fermentation of dietary fibers in the colon, leading to SCFAs 
production. Among the SCFAs, butyrate has received particular attention for its multiple beneficial 
effects from the intestinal tract to peripheral tissues [10]. Butyrate-producing bacteria represent a 
functional group, rather than a coherent phylogenetic group. Numerically, two of the most important 
groups of butyrate producers appear to be Faecalibacterium prausnitzii, which belongs to the 
Clostridium leptum (or clostridial cluster IV) cluster, and Eubacterium rectale/Roseburia spp., which 
belong to the Clostridium coccoides (or clostridial cluster XIVa) cluster of Firmicutes bacteria [54]. 
Studies have highlighted the profound effect of diet on gut microbiota composition and the connection 
to immune pathways [55–57]. Inadequate colonization of infant gut or alteration in the microbiota profile 
(dysbiosis) is now considered a strong risk factor for chronic disorders, such as allergic and autoimmune 
diseases [58–60]. A recent study found a significant relationship between gut microbiota constituents at 
one month of age and the later development of specific serum IgE against food proteins. In this study, 
952 participants of the Child, Parent and Health: Lifestyle and Genetic Constitution (KOALA) Birth 
Cohort Study provided a stool sample at one month of age and were characterized by cow’s milk, egg 
and peanut food-specific IgE measurement at 1, 2 and 67 months of age. Clostridium difficile was more 
often found in the fecal samples of subjects with a family history of allergic disease sensitized to food 
later in childhood [54]. Restoring the microbiota profile may be effective in the prevention or treatment 
of allergic and inflammatory diseases. These observations have led to the idea that probiotics, which 
have the potential to restore the intestinal microbiota balance, may be effective in preventing the 
development of chronic immune-mediated diseases [55]. Ghadimi et al. investigated the effects of two 
probiotics, Bifidobacterium breve (DSMZ 20213) and Lactobacillus rhamnosus GG (LGG) (ATCC 
53103), in an in vitro model of the intestinal mucosal immune system. The results of this study showed 
that probiotics can inhibit translation of IL-23, IL-17 and CD40 genes by epigenetic process involving 
reducing histone acetylation and enhancing DNA methylation [61]. A recent study showed that intestinal 
microbiota of pregnant women can play a very important role in epigenetic activation or suppression of 
gene expression in the pregnancy period, because SCFAs produced by indigenous gut and vaginal 
microbiota of pregnant women can penetrate via placenta into fetus and affect body composition in the 
natal and postnatal periods of life [17]. Therefore, diet or probiotic supplementation may induce an 
alteration of maternal indigenous microbial and long-term consequences in offspring by epigenetics 
mechanism that occur during embryonic and fetal development [39]. 
4. The Positive Role of Butyrate Epigenetic Effects on Children’s Health 
Butyrate has a pivotal role in the context of “gut/body health”. Its production is dependent on  
diet and intestinal microbiota composition. Butyrate is also able to modulate intestinal microbiota 
through regulation of lumen pH and to exert many beneficial extraintestinal effects through  
epigenetic mechanisms [62]. 
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Figure 1. The influences of early nutrition on the immune system. Dietary factors may 
induce direct epigenetic modifications and/or may influence epigenetic mechanisms through 
a modulation of gut microbiota composition and function. The short-chain fatty acid, 
butyrate, produced by gut microbiota exerts a broad range of epigenetic effects influencing 
immune system development and function. SCFAs, short-chain fatty acids. 
 
Butyrate exerts a general anti-inflammatory effect [63]. Mechanisms for butyrate anti-inflammatory 
functions are at least in part mediated through histone deacetylase (HDAC) inhibition and activation of 
metabolite-sensing G-protein-coupled receptors (GPCRs). GPCR signaling is a common pathway for K+ 
efflux or Ca2+ flux, and it is possible that this is central to the activation of the NALP3 inflammasome 
and production of IL-18 [64]. Most metabolite-sensing GPCRs and their ligands (including GPR43 and 
SCFAs, GPR120 and omega-3 fatty acids, GPR109A and butyrate and nicotinic acid and possibly 
GPR35 and kynurenic acid and pamoic acid) facilitate anti-inflammatory effects [65]. GPR43 (also 
called free fatty acid receptor 2 or Ffar2) and GPR109A appear to be important for gut homeostasis, and 
both are expressed by the colonic epithelium, by leukocytes (such as neutrophils and macrophages) and 
by Treg cells [66,67]. 
Lack of GPR109A, a metabolite sensor for butyrate, is associated with fewer colonic Treg cells as a 
result of the reduced ability of colonic macrophages and DCs to promote their development [67]. 
GPR43-deficient (Ffar2−/−) mice show exacerbated inflammation in models of airway hypersensitivity, 
DSS-induced colitis and rheumatoid arthritis when treated with SCFAs [65]. Smith et al. observed that 
SCFA treatment of Ffar2−/− mice and Ffar2+/+ littermates enhances Treg cell frequency and number in 
Ffar2+/+, but not for Ffar2−/− mice, suggesting that SCFA mediated enhanced Treg cells’ suppressive 
capacity was also dependent on Ffar2. They show also that SCFA treatment of Ffar2+/+ mice reduced 
Treg cells’ HDAC6 and HDAC9 expression and enhanced histone acetylation. These results suggest that 
SCFAs via Ffar2 may affect Treg cells through HDAC inhibition [67]. SCFAs are absorbed as anionic 
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forms or actively transported via monocarboxyl transporters (MCT1 and SMCT1) into colonocytes. 
Intracellular SCFAs regulate HDACs with respect to changes in gene expression and signal transduction. 
HDAC inhibition mediates the regulatory activities of SCFAs in cellular processes, such as the induction 
of antimicrobial peptides, mucins, trefoil factors (TFF), chemokines and cytokines, which together 
promote gut immunity and mediate intestinal inflammation [68]. Hamer et al. provided evidence that 
butyrate is able to suppress nuclear factor-B (Nf-κB) activation and interferon γ production and to 
upregulate peroxisome proliferator-activated receptor γ (PPARγ), through the inhibition of HDAC [53]. 
In ulcerative colitis (UC), butyrate metabolism is impaired due to a defect in the butyrate oxidation 
pathway and/or transport [69]. A defect in butyrate uptake deriving from reduced butyrate carrier MCT1 
(also called SLC16A1) mRNA levels at the gut level has been demonstrated in patients with UC [70].  
Santhanam et al. described a defect in the mitochondrial enzyme, acetoacetyl CoA thiolase (encoded by 
the gene ACAT2), in UC patients. This enzyme catalyzed the last step of butyrate oxidation and was 
significantly impaired in UC patients and unrelated to disease severity [71]. The mRNA expression of 
the other genes involved in the butyrate oxidation pathway was also downregulated in inflammatory 
disease [69]. 
Evidence is also emerging of microbial-derived molecules with neuroactive functions that can have 
influence across the brain-gut axis. For example, γ-aminobutyric acid, serotonin, catecholamines and 
acetylcholine may modulate neural signaling within the enteric nervous system, when released in the 
intestinal lumen, and, consequently, brain function [72]. Early exposure to gut microbiota is essential 
for the postnatal development of the enteric nervous system (ENS) [73]. In germ-free mice (GF), Collins 
et al. demonstrated that the myenteric plexus of the jejunum and ileum was abnormally patterned with 
an overall decrease in nerve density when compared with equivalent segments of small intestine from 
specific pathogen-free (SPF) colonized animals. Myenteric ganglia in GF mice, furthermore, contained 
fewer neuronal cell bodies than those found in SPF-colonized small intestine with an increase in the 
proportion of inhibitory nitrergic neurons [73]. In a double-blind, placebo-controlled, multicenter trial, 
51 patients with active distal ulcerative colitis (UC) were treated with rectal enemas containing either  
5-aminosalicylic acid (5-ASA) or 5-ASA plus sodium butyrate. The combined treatment with topical  
5-ASA plus sodium butyrate resulted in a significant improvement of the disease activity score compared 
to that observed in patients treated with 5-ASA alone [74]. Butyrate suppress the major TH1-skewing 
factors, IL-12 and IFN-γ, which influence the development of a subsequent T-cell response, and it 
increases the secretion of anti-inflammatory cytokines IL-10. However, this effect is not confirmed in 
all studies [75–77]. In addition, Usami et al. reported a reduced LPS-induced TNF-α secretion by 0.5 mM 
butyrate, indicating a therapeutic potential of butyrate by intravenous or oral administration [78]. An 
imbalance in gut microbiota composition has been also associated with food allergies. Recently, 
Nakayama et al. profiled the fecal bacteria compositions in allergic and non-allergic infants by using the 
16S rRNA gene short tag pyrosequencing approach and correlated some anomalies in the microbiota 
with allergy development in later years [79]. CD4+ Treg cells, which express the Foxp3 transcription 
factor, play a critical role in the maintenance of immune homeostasis and oral tolerance. Atarashi  
et al. [80] showed that in mice, the spore-forming component of indigenous intestinal microbiota, 
particularly clusters IV and XIVa of the genus, Clostridium, major butyrate producers, promotes Treg 
cell accumulation in the colonic mucosa. Our study showed that treatment of cow’s milk allergy (CMA) 
infants with an extensively hydrolyzed casein formula (eHCF) supplemented with the probiotic, LGG, 
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accelerates oral tolerance acquisition to cow’s milk [81,82]. We tested also the hypothesis that eHCF 
plus LGG induced an effect on oral tolerance thanks to the influence of this dietary intervention on the 
composition of the gut microbiota [83]. Treatment with eHCF plus LGG expanded gut microbiota 
populations in newly diagnosed CMA infants, was associated with immunoregulatory effects and 
significantly increased butyrate production at the intestinal level. The protective effects of butyrate were 
also explored in a mouse model of CMA, where oral butyrate treatment alleviates the allergic response 
in β-lactoglobulin-sensitized mice [84]. These findings suggest a potential innovative therapeutic 
approach for infants affected by CMA, based on the effect of bacterial metabolites on host immunity and 
human health. 
5. Conclusions 
Nutriepigenomics is an emerging discipline examining the role of dietary influences on gene 
expression. An increasing amount of evidence suggests the pivotal role of epigenetic mechanisms in 
many positive effects elicited by nutrients and by diet-induced regulation of gut microbiota composition 
and function. The potential of these epigenetic mechanisms may represent innovative targets for new 
preventive and therapeutic strategies for a wide number of immune-mediated diseases. 
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